EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter surveillance of non-albicans candidemia



Multicenter surveillance of non-albicans candidemia



Clinical Infectious Diseases 31(1): 219, July




(PDF 0-2 workdays service: $29.90)

Accession: 035349953

Download citation: RISBibTeXText



Related references

Prospective multicenter surveillance study of ICU-acquired candidemia and candiduria The candidemia analysis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 349, 2003

Molecular surveillance of candidemia due to Candida albicans among cancer patients during 2009 to 2013 by microsatellite typing. Microbial Pathogenesis 81(): 28-32, 2015

Candidemia surveillance in Brazil: evidence for a geographical boundary defining an area exhibiting an abatement of infections by Candida albicans group 2 strains. Journal of Clinical Microbiology 48(9): 3062-3067, 2010

Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. Journal of Clinical Microbiology 44(8): 2816-2823, 2006

Prospective multicenter surveillance study of ICU-acquired candidemia and candiduria The candiduria analysis. Abstracts Of The Interscience Conference On Antimicrobial Agents & Chemotherapy. 43: 348, 2003

Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group. European Journal of Clinical Microbiology & Infectious Diseases 16(5): 337-345, 1997

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infection Control and Hospital Epidemiology 26(6): 540-547, 2005

Candidemia in cancer patients A prospective, multicenter surveillance study by the invasive fungal infection group of the European Organization for Research and Treatment of Cancer. Clinical Infectious Diseases 28(5): 1071-1079, 1999

Risk factors for albicans and non-albicans candidemia in the intensive care unit. Critical Care Medicine 36(7): 1993-1998, 2008

Comparison of albicans vs. non-albicans candidemia in French intensive care units. Critical Care 14(3): R98-R98, 2011

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clinical Infectious Diseases 28(5): 1071-1079, 1999

Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Annals of PharmacoTherapy 41(4): 568-573, 2007

Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. International Journal of Infectious Diseases 14(11): E954-E966, 2011

Comment: Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Annals of PharmacoTherapy 41(11): 1916-7; Author Reply 1917, 2007

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrobial Agents and ChemoTherapy 39(1): 40-44, 1995